Status:
COMPLETED
Blood Spot Self-administered Test and Assay
Lead Sponsor:
University of Pennsylvania
Conditions:
Dysfunction; Endocrine
Effects of Chemotherapy
Eligibility:
FEMALE
18-45 years
Brief Summary
The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal me...
Detailed Description
Recent advances in cancer diagnosis and treatment have led to greater survival rates in patients with malignancies. However, these life-saving treatments, especially alkylating agents, often lead to p...
Eligibility Criteria
Inclusion
- Adult females
- Age between 18-45 years
- Premenopausal (defined as menses in the past 12 months)
- Postmenarchal
- Presence of an intact uterus and two ovaries
- Ability and willingness to comply with study protocol
Exclusion
- Pregnancy within the previous 3 months
- Lactation within the previous 3 months
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03840824
Start Date
October 1 2010
End Date
August 1 2016
Last Update
February 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania, Reproductive Research Unit
Philadelphia, Pennsylvania, United States, 19143